Skip to main content
background gradient

Volume 14Issue 12

Industry Update

Open Access
R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 22
  • Paul Arora and
  • Sreeram V Ramagopalan
e250149
Published Online:16 October 2025
Preview Abstract
Open Access
Access in all areas? A round-up of developments in market access and health technology assessment: part 11
  • Sreeram V Ramagopalan,
  • Annie Jullien Pannelay, and
  • Jo Atkins
e250176
Published Online:4 November 2025
Preview Abstract

Letter to the Editor

Letter in Reply

Open Access
Letter in Reply – Quality in qualitative evidence: new best practice principles from NICE’s real-world evidence framework
  • Vandana Ayyar Gupta,
  • Sarah Scott,
  • Mandy Tonkinson,
  • Pall Jonsson,
  • Lesley Goodburn, and
  • Stephen Duffield
e250154
Published Online:30 October 2025

Research Article

Open Access
Iron deficiency treatment pathway in Italy: patients’ perceptions of diagnosis and treatment
  • Ovidio Brignoli,
  • Rose-Marie Carneiro,
  • Cécile Fournier,
  • Ettore Pinardi, and
  • Maurizio Serati
e250011
Published Online:28 November 2025
Preview Abstract
Open Access
Cost-effectiveness of PD-L1 testing to guide immunotherapy for patients with advanced non-small-cell lung cancer in China
  • Fei Zhou,
  • Yuan Li,
  • Jian Ming,
  • Yingyao Chen, and
  • Caicun Zhou
e250093
Published Online:14 November 2025
Preview Abstract
Open Access
Comparison treatments for basal ganglia hemorrhage: minimally invasive puncture and drainage versus craniotomy versus conservative treatment
  • Tao Tang,
  • Jing Liu,
  • Bo Gao,
  • Yu Gao,
  • Gaopan Zhang, and
  • Gang Guo
e250097
Published Online:27 November 2025
Preview Abstract
Open Access
Adherence, treatment utilization, clinical and economic outcomes of patients with sickle cell disease with recurrent vaso-occlusive crises treated with recently approved chronic therapies in the US
  • Chuka Udeze,
  • Michelle Jerry,
  • Kristin Evans,
  • Nanxin Li,
  • Siddharth Jain, and
  • Biree Andemariam
e240232
Published Online:24 November 2025
Preview Abstract
Open Access
Association of liver biomarker values beyond current thresholds and negative clinical outcomes in primary biliary cholangitis: analysis of a real-world healthcare claims database
  • Timothy E Ritter,
  • Christina J Hanson,
  • Christopher Fernandes,
  • Joanna P MacEwan,
  • Xin Zhao,
  • Craig S Parzynski,
  • Daniel Mercer,
  • Erik Ness,
  • Darren Wheeler,
  • Kris V Kowdley, and
  • Tracy Mayne
e240198
Published Online:18 November 2025
Preview Abstract
Open Access
Matching-adjusted indirect comparison of kidney function in patients with immunoglobulin A nephropathy treated with nefecon or sparsentan
  • Christopher Ngai,
  • Mit Patel,
  • Agnieszka Kopiec,
  • Shuai Fu, and
  • Noemi Hummel
e250045
Published Online:20 November 2025
Preview Abstract

Review

Open Access
Real-world evidence of pimavanserin utilization among patients with Parkinson’s disease psychosis: a review of real-world data that augments data from randomized controlled trials
  • Nazia Rashid,
  • Ismaeel Yunusa,
  • Dilesh Doshi,
  • Vinod Yakkala,
  • Daksha Gopal,
  • Victor Abler, and
  • Krithika Rajagopalan
e250129
Published Online:27 October 2025
Preview Abstract

Perspective

Open Access
Bridging the patient gap: exploring generative AI to support meaningful patient involvement in health technology assessment
  • Manuel Cossio and
  • Ramiro E Gilardino
e250150
Published Online:4 November 2025
Preview Abstract